Icon

CIPRO (nda019537)- (EQ 250MG BASE,EQ 500MG BASE,EQ 750MG BASE)

CIPROFLOXACIN HYDROCHLORIDE BAYER HLTHCARE
EQ 250MG BASE,EQ 500MG BASE,EQ 750MG BASE
Yes No
2011-Aug-15 Expired
None None
None No
CIPRO is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: • Skin and Skin Structure Infections • Bone and Joint Infections • Complicated Intra-Abdominal Infections • Infectious Diarrhea • Typhoid Fever (Enteric Fever) • Uncomplicated Cervical and Urethral Gonorrhea • Inhalational Anthrax post-exposure in adult and pediatric patients • Plague in adult and pediatric patients • Chronic Bacterial Prostatitis • Lower Respiratory Tract Infections: Acute Exacerbation of Chronic Bronchitis • Urinary Tract Infections: Urinary Tract Infections (UTI), Acute Uncomplicated Cystitis, Complicated UTI and Pyelonephritis in Pediatric Patients • Acute Sinusitis.
12 0 10
Total Other Developers 8
Drugs with Suitability No
EQ 250MG BASE ** ** - - 9
EQ 500MG BASE ** ** - - 8
EQ 750MG BASE ** ** - - 7
NDA Sales Available Total Generic Sales Available
Yes 8
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ** ****** **** *** **. *****'* ************ *********, *** *********** **** **** ******, **********, ********* (**) *****, ****** ****** (***) ***
****** ******** ******** **********, ***. *********** **** ******* **, ********, ********** (**) *****, ****** ****** (***) ***
****** ***** ***** *************** *** *********** ****** *** ** ******, ********** ****, ******** **. **, ******* **** ** ****, **. ******, *****, *****, ****** (***) ***
****** ***** ***** ******** *.*.*. *********** ****** ****** ********** **, ******, *****, ******* (***) ***
****** ***** ***** *************** *** *********** ***** *************** ****** *** ** ****** ******, ******** **. (**) ******* **** ** **** ********** **** *.*.*** ****** ***** ***** ****** (***), *****, ***** *****, ****** (***) ***
****** ****** * * ********* *** *************** ******* *********** **** **. ***-***, *.*.*.* ********** ****, *******, ******, ***** (***) ***
****** **** **** ************** ********** ***. *********** ** ******* ******, ***** ***, *******, ****** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ****** ****** ************** *** *********** **.** ******** ****, ************, ******, ***** (***) ***
****** ****** ***** *** ******** ******* ************** **., ***. *********** **.***, ******** ***. **** **., ***** **., ******** ******, ********, ******** ******, ***** (***) ***
****** ***** ***** *************** *** *** *********** ***** *************** ****** *** ** ****** ******, ******** **. (**) ******* **** ** **** ********** **** *.*.*** ****** ***** ***** ****** (***), *****, ***** *****, ****** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ***** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.